Literature DB >> 2905656

Prenatal DNA analysis in four embryos/fetuses at risk of 21-hydroxylase deficiency.

T Matsumoto1, T Kondoh, T Kamei, M Yoshimoto, Y Tsuji, K Suzumori, R Izumi, N Iwatani, N Niikawa.   

Abstract

Prenatal diagnosis of 21-hydroxylase deficiency (21-OHD) in two unrelated embryos and two fetuses was attempted with the Southern hybridization method using the 21-hydroxylase (21-OHase) complementary DNA as a probe. The two embryos whose genomic DNA was extracted from their chorionic villi both had four TaqI fragments (3.7 kb, 3.2 kb, 2.4 kb and 2.3 kb) identical to those of their respective parents and normal controls, while the DNA from each proband of these two families lacked with the 3.7 kb and the 2.3 kb fragments corresponding to the functional 21-OHase gene (21-OHase B gene). These findings indicated that none of the embryos examined were deletion homozygotes for the 21-OHase B gene. In the two fetuses, only amniotic fluid cells were available for prenatal diagnosis. The results of Southern hybridization analysis were uninformative since all family members, including the probands and fetuses, had all four TaqI fragments. Linkage studies between 21-OHD and human leukocyte antigen (HLA) haplotypes and those between the disease and restriction fragment length polymorphisms of the 4th complement gene revealed that the fetus of one family was normal. The other fetus could not be diagnosed because a recombination between the class I HLA and the 21-OHD loci had occurred in this family.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905656     DOI: 10.1007/BF00441409

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

Review 1.  Congenital adrenal hyperplasia (2).

Authors:  P C White; M I New; B Dupont
Journal:  N Engl J Med       Date:  1987-06-18       Impact factor: 91.245

2.  Late-onset form of congenital adrenal hyperplasia in the HLA-B14; DR1 haplotype is caused by a duplication in the 21-OH MHC gene region.

Authors:  B O Boehm; C Rosak; P Kuehnl; K Schöffling
Journal:  Horm Metab Res       Date:  1986-11       Impact factor: 2.936

3.  Localization of the human prealbumin gene to 18p11.1-q12.3 by gene dose effect study of Southern blot hybridization.

Authors:  Y Jinno; T Matsumoto; T Kamel; T Kondoh; S Maeda; S Araki; K Shimada; N Niikawa
Journal:  Jinrui Idengaku Zasshi       Date:  1986-09

Review 4.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

5.  Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congenital adrenal hyperplasia.

Authors:  N Jospe; P A Donohoue; C Van Dop; R H McLean; W B Bias; C J Migeon
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

6.  Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria.

Authors:  R Chakraborty; A S Lidsky; S P Daiger; F Güttler; S Sullivan; A G Dilella; S L Woo
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

7.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.

Authors:  M C Carroll; R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.

Authors:  Y Higashi; H Yoshioka; M Yamane; O Gotoh; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Associations between restriction fragment length polymorphisms detected with a probe for human 21-hydroxylase (21-OH) and two clinical forms of 21-OH deficiency.

Authors:  E Mornet; P Couillin; F Kutten; M C Raux; P C White; D Cohen; A Boué; J Dausset
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

10.  Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia.

Authors:  M I Evans; G P Chrousos; D W Mann; J W Larsen; I Green; J McCluskey; D L Loriaux; J C Fletcher; G Koons; J Overpeck
Journal:  JAMA       Date:  1985-02-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.